0.57 Zydus Lifesciences concludes subject enrolment in Phase II ALS trial

News


<< back

Zydus Lifesciences concludes subject enrolment in Phase II ALS trial
Date: 2024-05-24 [news.yahoo.com]

READ THE FULL NEWS >>
×